Company Valuation: Profarma Distribuidora de Produtos Farmacêuticos S.A.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 747.9 723.4 450 747.9 795.7 1,119
Change - -3.28% -37.8% 66.21% 6.39% 40.68%
Enterprise Value (EV) 1 1,277 1,482 1,291 1,698 1,813 2,286
Change - 16.05% -12.88% 31.53% 6.77% 26.1%
P/E 14.3x 9.25x 5.56x 10.6x 6.95x 9.42x
PBR 0.71x 0.67x 0.38x 0.6x 0.61x 0.83x
PEG - 0.2x 1.62x -0.8x 0.1x 2.46x
Capitalization / Revenue 0.14x 0.11x 0.06x 0.09x 0.08x 0.1x
EV / Revenue 0.23x 0.23x 0.17x 0.2x 0.18x 0.2x
EV / EBITDA 8.52x 9.11x 4.54x 5.74x 5.3x 5.65x
EV / EBIT 9.95x 10.9x 5.09x 6.5x 6.05x 6.53x
EV / FCF -50.4x -136x -22.6x -101x 11.3x 34.7x
FCF Yield -1.98% -0.73% -4.42% -0.99% 8.82% 2.88%
Dividend per Share 2 - 0.2706 0.1733 0.3858 0.575 -
Rate of return - 4.59% 4.72% 6.32% 8.86% -
EPS 2 0.4268 0.6377 0.6596 0.574 0.934 0.9697
Distribution rate - 42.4% 26.3% 67.2% 61.6% -
Net sales 1 5,481 6,413 7,816 8,662 10,154 11,451
EBITDA 1 149.9 162.7 284.2 295.6 342.1 404.5
EBIT 1 128.3 136.3 253.8 261.1 299.7 350.1
Net income 1 52.33 78.19 80.87 70.4 114.6 118.9
Net Debt 1 528.9 758.4 840.9 950 1,017 1,167
Reference price 2 6.100 5.900 3.670 6.100 6.490 9.130
Nbr of stocks (in thousands) 122,611 122,611 122,611 122,611 122,611 122,611
Announcement Date 16/3/21 16/3/22 15/3/23 7/3/24 18/3/25 17/3/26
1BRL in Million2BRL
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 156M
18.06x0.22x12.53x0.44% 89.39B
30.64x0.24x15.31x0.87% 55.72B
43.42x3.07x28.48x1.43% 22B
10.61x0.19x4.57x2.83% 7.63B
11.76x0.89x7.2x2.87% 6.81B
5.51x0.09x2.58x5.45% 6.28B
9.32x1.74x5.55x3.51% 6.18B
24.37x1.17x14.47x2.96% 5.28B
9.89x0.11x4.02x4.52% 3.39B
Average 18.18x 0.86x 10.52x 2.76% 20.28B
Weighted average by Cap. 23.15x 0.62x 13.93x 1.22%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. PFRM3 Stock
  4. Valuation Profarma Distribuidora de Produtos Farmacêuticos S.A.